Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Biochim Biophys Acta Rev Cancer. 2020 Dec 1;1875(1):188486. doi: 10.1016/j.bbcan.2020.188486

Fig. 4.

Fig. 4.

Peptides targeting TAMs. Several peptides binding CD206, which is a prominent biomarker of M2-like macrophages, have been developed. IL-4R is also highly expressed on M2-like macrophages. M2pepKLA is another peptide binding M2-like macrophages although the binding target is unknown. Peptide R is a CXCR4 inhibitory peptide which promotes the M1 feature of TAMs.